Treatment of Patients With Recently Exacerbated Schizophrenia With Paliperidone Palmitate - A Pilot Study.
Phase of Trial: Phase III
Latest Information Update: 05 Nov 2014
At a glance
- Drugs Paliperidone (Primary)
- Indications Schizophrenia
- Focus Registrational; Therapeutic Use
- Sponsors Janssen-Cilag
- 27 Jan 2014 Status changed from recruiting to completed as reported by ClinicalTrials.gov record.
- 19 Aug 2013 Planned end date changed from 1 Nov 2013 to 1 Dec 2013 as reported by ClinicalTrials.gov.
- 15 Apr 2013 Planned End Date changed from 1 May 2013 to 1 Nov 2013 as reported by ClinicalTrials.gov.